carbon monoxide has been researched along with 1-methyl-3-isobutylxanthine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laitinen, JT; Laitinen, KS; Salovaara, K; Severgnini, S | 1 |
Friebe, A; Koesling, D; Müllershausen, F; Schultz, G; Smolenski, A; Walter, U | 1 |
2 other study(ies) available for carbon monoxide and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Regulation of cyclic GMP levels in the rat frontal cortex in vivo: effects of exogenous carbon monoxide and phosphodiesterase inhibition.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Carbon Monoxide; Cyclic GMP; Enzyme Inhibitors; Frontal Lobe; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Rats; Rats, Wistar | 1997 |
YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
Topics: 1-Methyl-3-isobutylxanthine; Blood Platelets; Carbon Monoxide; Cyclic AMP; Cyclic GMP; Drug Synergism; Humans; Indazoles; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphorylation; Platelet Aggregation Inhibitors; Vasodilator Agents | 1998 |